Changmao Biochemical Engineering Company Limited provided preliminary consolidated earnings outlook for the year ended December 31, 2013. For the period, the company expects its net profit to increase significantly as compared with that of the year ended December 31, 2012. Such expected increase was mainly due to the increase in gross profit margin of the Group as a result of the effective cost control measures taken by the Group and the increase in average selling price of some major organic acid products compared to that in 2012.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.43 HKD | 0.00% |
|
+2.38% | -27.12% |
03-26 | Changmao Biochemical Engineering Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
02-29 | Changmao Biochemical Engineering to Swing to Loss in 2023 | MT |
1st Jan change | Capi. | |
---|---|---|
-27.12% | 29.17M | |
+0.73% | 99.64B | |
-11.98% | 58.77B | |
+75.71% | 48.81B | |
+5.26% | 34.94B | |
+3.47% | 18.62B | |
+17.33% | 17.44B | |
+5.92% | 13.51B | |
-6.67% | 12.73B | |
-25.86% | 12.04B |
- Stock Market
- Equities
- 954 Stock
- News Changmao Biochemical Engineering Company Limited
- Changmao Biochemical Engineering Company Limited Provides Preliminary Consolidated Earnings Outlook for the Year Ended December 31, 2013